GlassScriptPhysician profile
Mohammed W Farra
NPI 1609871771
$19,882.77
in general payments reported to CMS, 2019-2025
48 companies · $3,410 in 2025
The $3,410 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,068 · 2020: $1,922 · 2021: $2,477 · 2022: $2,492 · 2023: $2,873 · 2024: $4,641 · 2025: $3,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,719 · Education: $4,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,719.42 |
| Education | $4,204.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,063.30 | 2024-2025 | |
| Glaxosmithkline, LLC. | $3,042.55 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,361.23 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,676.48 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Mylan Specialty L.P. | $1,276.35 | 2019-2024 | Yupelri |
| Genzyme Corporation | $883.86 | 2019-2025 | |
| United Therapeutics Corporation | $791.07 | 2019-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $689.21 | 2019-2025 | Dupixent |
| Insmed, INC. | $653.27 | 2019-2025 | Arikayce, Brinsupri |
| Pulmonx Corporation | $409.41 | 2020-2025 | Chartis Catheter, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Grifols USA, LLC | $314.77 | 2020-2023 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $309.93 | 2023-2025 | Sunosi |
| Actelion Pharmaceuticals US, INC. | $292.62 | 2019-2023 | Uptravi, Opsumit |
| Amgen INC. | $291.57 | 2021-2025 | Tezspire |
| Csl Behring | $266.56 | 2019-2024 | Kcentra |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $252.96 | 2019-2024 | Xarelto |
| Gilead Sciences, INC. | $249.22 | 2022-2024 | Veklury |
| Bard Access Systems, INC. | $233.57 | 2019-2020 | |
| Inspire Medical Systems, INC. | $201.87 | 2023-2025 | Inspire |
| Inari Medical, INC. | $170.04 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Circassia INC. | $153.34 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $117.22 | 2019 | |
| Merck Sharp & Dohme LLC | $97.00 | 2019-2024 | Keytruda |
| Mallinckrodt Hospital Products INC. | $91.54 | 2020-2024 | Acthar |
| Philips North America LLC | $85.04 | 2020-2025 | Vest Therapy Und |
| Electromed, INC. | $79.42 | 2022-2025 | Smartvest |
| E.R. Squibb & Sons, L.L.C. | $78.52 | 2020-2022 | |
| Ani Pharmaceuticals, INC. | $77.16 | 2024-2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $68.96 | 2019-2021 | |
| Getinge USA Sales, LLC | $62.59 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $61.65 | 2021 | |
| Paratek Pharmaceuticals, INC. | $61.13 | 2021-2023 | Nuzyra |
| Takeda Pharmaceuticals U.S.A., INC. | $56.59 | 2020-2021 | |
| Harmony Biosciences LLC | $40.76 | 2020 | |
| Advanced Respiratory, INC | $39.75 | 2019-2020 | |
| Pfizer INC. | $37.26 | 2020-2023 | |
| Inogen, INC. | $33.31 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Baxter Healthcare | $31.69 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Edwards Lifesciences Corporation | $25.50 | 2024 | Hemosphere |
| Veran Medical Technologies, INC. | $21.10 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.61 | 2023 | |
| Novo Nordisk INC | $18.58 | 2024 | |
| Zoll Respicardia, INC. | $17.36 | 2024 | Remede System |
| Covis Pharma Gmbh | $17.24 | 2022 | |
| Jazz Pharmaceuticals INC. | $16.40 | 2021 | |
| Vapotherm INC | $16.25 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.71 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $14.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Farra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.